These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34663487)

  • 1. Leukodystrophy Due to
    Shivaram S; Nagappa M; Seshagiri DV; Saini J; Govindaraj P; Sinha S; Bindu PS; Taly AB
    Can J Neurol Sci; 2022 Sep; 49(5):708-712. PubMed ID: 34663487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia.
    Wei C; Qin Q; Chen F; Zhou A; Wang F; Zuo X; Chen R; Lyu J; Jia J
    BMC Neurol; 2019 Aug; 19(1):203. PubMed ID: 31438897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset leukodystrophy with vanishing white matter: a case series of 19 patients.
    Benzoni C; Moscatelli M; Farina L; Magri S; Ciano C; Scaioli V; Alverà S; Cammarata G; Bianchi-Marzoli S; Castellani M; Zito FM; Marotta G; Piacentini S; Villacara A; Mantegazza R; Gellera C; Durães J; Gouveia A; Matos A; do Carmo Macário M; Pareyson D; Taroni F; Di Bella D; Salsano E
    J Neurol; 2023 Sep; 270(9):4219-4234. PubMed ID: 37171481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice.
    Lin Y; Pang X; Huang G; Jamison S; Fang J; Harding HP; Ron D; Lin W
    J Neurosci; 2014 Sep; 34(36):12182-91. PubMed ID: 25186761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of eIF2B bodies and their relationships with stress granules and P-bodies.
    Moon SL; Parker R
    Sci Rep; 2018 Aug; 8(1):12264. PubMed ID: 30115954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult Vanishing White Matter Disease with a Novel EIF2B4 Mutation.
    Su T; Yuan H; Gao W; Li H; Yuan M
    J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS181-SS183. PubMed ID: 36597332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature.
    Klingelhoefer L; Misbahuddin A; Jawad T; Mellers J; Jarosz J; Weeks R; Ray Chaudhuri K
    Pediatr Neurol; 2014 Jul; 51(1):157-64. PubMed ID: 24938145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanishing white matter: Eukaryotic initiation factor 2B model and the impact of missense mutations.
    Slynko I; Nguyen S; Hamilton EMC; Wisse LE; de Esch IJP; de Graaf C; Bruning JB; Proud CG; Abbink TEM; van der Knaap MS
    Mol Genet Genomic Med; 2021 Mar; 9(3):e1593. PubMed ID: 33432707
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Moon SL; Parker R
    RNA; 2018 Jun; 24(6):841-852. PubMed ID: 29632131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and
    Trevisan L; Grazzini M; Cianflone A; Accogli A; Finocchi C; Capello E; Saitta L; Grandis M; Roccatagliata L; Mandich P
    Neurocase; 2021 Dec; 27(6):452-456. PubMed ID: 34751098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
    Labauge P; Fogli A; Niel F; Rodriguez D; Boespflug-Tanguy O
    Rev Neurol (Paris); 2007 Sep; 163(8-9):793-9. PubMed ID: 17878805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Energy Status of Astrocytes Is the Achilles' Heel of eIF2B-Leukodystrophy.
    Herrero M; Daw M; Atzmon A; Elroy-Stein O
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarioleukodystrophy due to EIF2B5 mutations.
    Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
    Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes.
    Wong YL; LeBon L; Edalji R; Lim HB; Sun C; Sidrauski C
    Elife; 2018 Feb; 7():. PubMed ID: 29489452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients.
    Ren Y; Yu X; Chen B; Tang H; Niu S; Wang X; Pan H; Zhang Z
    Neurol Sci; 2022 Aug; 43(8):4961-4977. PubMed ID: 35389136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype.
    Alsalem A; Shaheen R; Alkuraya FS
    Gene; 2012 Apr; 496(2):141-3. PubMed ID: 22285377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unmasked mutation of EIF2B2 due to submicroscopic deletion of 14q24.3 in a patient with vanishing white matter disease.
    Shimada S; Miya K; Oda N; Watanabe Y; Kumada T; Sugawara M; Shimojima K; Yamamoto T
    Am J Med Genet A; 2012 Jul; 158A(7):1771-7. PubMed ID: 22678813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
    Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
    Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanishing white matter: deregulated integrated stress response as therapy target.
    Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Missense Variant in the EIF2B3 Gene Causing Vanishing White Matter Disease with Antenatal-Onset but Mild Symptoms and Long-Term Survival.
    Khorrami M; Khorram E; Yaghini O; Rezaei M; Hejazifar A; Iravani O; Yazdani V; Riahinezhad M; Kheirollahi M
    J Mol Neurosci; 2021 Nov; 71(11):2405-2414. PubMed ID: 33687620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.